Atlas Trials

Obtain Safety and Effectiveness of CT-ACL001, a Regenerative Ligament Using Biological Tissue, in ACLR

Clinical trial NCT07129694 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07129694
Sponsor
CoreTissue BioEngineering Inc.
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
Anterior Cruciate Ligament Rupture
Start date
2024-11-25
Primary completion
2026-11-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.